BIOSYENT INC earnings per share and revenue

RX earnings per share for the last quarter are 0.12 CAD whereas the estimation was 0.17 CAD which accounts for -29.41% surprise. Företagets omsättning för samma period uppgår till 8.27 M CAD trots den uppskattade siffran 8.80 M CAD. Estimated earnings per share for the next quarter are 0.08 CAD, and revenue is expected to reach 7.90 M CAD. Also watch annual changes over time to get a bigger picture of RX earnings per share and revenue dynamics.